Parkinson's disease (PD) is a progressive debilitating neurodegenerative disorder for which there is no cure. The objective of this research project is to determine if central nervous system (CNS) grafting can improve the fixed neurological symptoms of parkinsonism. The MPTP-induced parkinson-like syndrome is an excellent model. to test surgical techniques for CNS transplantation. Our previous investigations have demonstrated the potential for correcting these Parkinson-like movement abnormalities using either adrenal medullary and sural nerve co-grafts or fetal ventral mesencephalon cell suspensions in the rhesus monkey (Macaca mulatta). The goal of this research is to determine the best tissue for CNS transplantation. The quantification of behavioral recovery of motor deficits will be the key determinant of graft success. Behavioral assessment of motor activity is evaluated by clinical examination, computerized image analysis of spontaneous cage activity, drug-induced rotation, and performance on a learned visual-motor forelimb task. Quantification of motor activity , especially speed of movement, provides an index of the severity of bradykinesia - the most debilitating symptom of parkinsonism. Each monkey will be tested prior to the administration of MPTP, after stabilization of the Parkinson-like state, and postoperatively, thus allowing each monkey to serve as its own control. Anatomical assessment permits comparison of surgical treatment groups by quantification of loss of dopaminergic cells in the substantia nigra determined by tyrosine hydroxylase immunoreactivity. Graft survival is evaluated by counting cells which are immunocytochemically reactive for tyrosine hydroxylase, dopamine-B-hydroxylase, or chromagranin A. Biochemical assessment is performed by serial measurements of dopamine metabolites in the CSF, and by measurement of tissue concentrations of dopamine and its metabolites as well as tyrosine hydroxylase synthetic activity in the neostriatum and graft. The important question is not only which tissue is best, but also how well it corrects the Parkinson symptoms. If the severe neurologic deficits can be successfully improved in nonhuman primates with this' Parkinson-like syndrome, the implications are extremely important not only for the potential clinical treatment of parkinsonism but also for the possible repair and restoration of CNS deficits following disease or injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS024340-04A1
Application #
3408839
Study Section
Neurology A Study Section (NEUA)
Project Start
1989-04-01
Project End
1996-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Other Domestic Higher Education
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Howel, L L; Byrd, L D; McDonough, A M et al. (2000) Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation. Cell Transplant 9:609-22
Starr, P A; Wichmann, T; van Horne, C et al. (1999) Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Cell Transplant 8:37-45
Bakay, R A; Boyer, K L; Freed, C R et al. (1998) Immunological responses to injury and grafting in the central nervous system of nonhuman primates. Cell Transplant 7:109-20
Betarbet, R; Zigova, T; Bakay, R A et al. (1996) Migration patterns of neonatal subventricular zone progenitor cells transplanted into the neonatal striatum. Cell Transplant 5:165-78
Betarbet, R; Zigova, T; Bakay, R A et al. (1996) Dopaminergic and GABAergic interneurons of the olfactory bulb are derived from the neonatal subventricular zone. Int J Dev Neurosci 14:921-30
Ansari, A A; Mayne, A; Freed, C R et al. (1995) Lack of a detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease. Transplant Proc 27:1401-5
Watts, R L; Mandir, A S; Bakay, R A (1995) Intrastriatal cografts of autologous adrenal medulla and sural nerve in MPTP-induced parkinsonian macaques: behavioral and anatomical assessment. Cell Transplant 4:27-38
Bakay, R A (1993) Neurotransplantation: a clinical update. Acta Neurochir Suppl (Wien) 58:8-16
Ellis, J E; Byrd, L D; Bakay, R A (1992) A method for quantitating motor deficits in a nonhuman primate following MPTP-induced hemiparkinsonism and co-grafting. Exp Neurol 115:376-87
Besharse, J C; Iuvone, P M (1992) Is dopamine a light-adaptive or a dark-adaptive modulator in retina? Neurochem Int 20:193-9